BeStock  
Stocks › Biotechnology › IVA

Inventiva IVA

US equityMarket cap rank #3415Biotechnology
$3.37 −$0.10 (-2.75%)
Pre-market · Oct 8, 8:20 am ET · After hours $3.37 0.00%
Open$3.46
Prev close$3.46
Day range$3.28 – $3.46
Volume2.40M
Market cap$794.93M
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership93.0%+0.01 pts vs. prior quarter
Institutions holding113+1 vs. prior quarter
Short interest2.05% of floatDays to cover 3.6 · as of 15 Sep 2026
Short-sale volume share18.9%5-day average of daily volume

Short-sale volume as % of daily volume

8%13%19%24%Sep '26Sep '26Oct '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: +$1.72M (12 inflow days, 8 outflow days).

Net flow by order size, last 20 sessions

−$460.2KSuper+$2.2MBig+$1.5MMid+$107.1KSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 35.2% of shares outstanding.

Largest holders

  • JPMorgan Chase & Co.9.45%
  • Artal Group S.A.6.80%
  • Andera Partners6.74%
  • Sofinnova Partners SAS6.43%
  • Samsara BioCapital LLC5.73%
  • BVF Partners L.P.4.63%
  • Deep Track Capital, LP4.40%
  • Eventide Asset Management, LLC4.39%

By investor type

  • VC/PE Fund42.25%
  • Hedge Fund25.86%
  • Mutual Fund13.57%
  • Public Company10.76%
  • Individual/Insider4.08%
  • Private Company0.52%
  • Government Pension Fund0.01%
  • Family Office/Trust0.00%

Reported short interest has risen from 0.60% to 2.05% of float over the last 6 biweekly reports (30 Jun 2026 to 15 Sep 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Caligan Partners, LP Hedge Fund 2026/Q3 +3,188,285 3.5%
Nantahala Capital Management, LLC Hedge Fund 2026/Q3 +2,686,393 1.1%
Deep Track Capital, LP VC/PE Fund 2026/Q3 +2,602,332 4.4%
BVF Partners L.P. Hedge Fund 2026/Q3 +2,404,000 4.6%
Woodline Partners LP Hedge Fund 2026/Q3 +2,323,149 1.0%
abrdn plc Mutual Fund 2026/Q3 +2,307,773 1.0%
JPMorgan Chase & Co. Public Company 2026/Q3 +2,055,722 9.5%
Patient Square Capital, LP VC/PE Fund 2026/Q3 +1,967,171 0.8%
Squadron Capital Management LLC Hedge Fund 2026/Q3 +1,900,000 1.0%
Andera Partners VC/PE Fund 2026/Q3 +1,815,000 6.7%
Citadel Advisors LLC Hedge Fund 2026/Q3 +1,719,616 0.8%
ADAR1 Capital Management, LLC Hedge Fund 2026/Q3 +1,432,258 1.5%
StemPoint Capital LP Hedge Fund 2026/Q3 +1,426,320 0.6%
Kingdon Capital Management, L.L.C. Hedge Fund 2026/Q3 +1,270,000 0.5%
Integral Health Asset Management, LLC Hedge Fund 2026/Q3 +1,120,000 0.6%

Institutional buy/sell activity by reporting period, largest moves first.

Short interest, by report

Report dateShares short% of floatDays to cover
15 Sep 2026 4,853,831 2.1% 3.6
31 Aug 2026 3,684,862 1.6% 5.3
14 Aug 2026 2,580,307 1.1% 4.4
31 Jul 2026 2,195,099 0.9% 2.7
15 Jul 2026 1,787,962 0.8% 1.0
30 Jun 2026 1,424,175 0.6% 1.0

Discussion

No comments yet — be the first to weigh in on IVA.

Leave a comment

Scroll to Top